🔎 Trials Near Me

Beranda › Adenokarsinoma Esofagus › Oregon

Uji klinis Adenokarsinoma Esofagus di Oregon

6 studi untuk Adenokarsinoma Esofagus mencari peserta di lokasi di Oregon.

Kota di Oregon

Teks studi resmi (Bahasa Inggris)

Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial

  • Saint Alphonsus Cancer Care Center-Ontario, Ontario
  • Providence Portland Medical Center, Portland
  • Providence Saint Vincent Medical Center, Portland
  • dan 1 lainnya
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06203600

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

  • Saint Alphonsus Cancer Care Center-Baker City, Baker City
  • Clackamas Radiation Oncology Center, Clackamas
  • Providence Newberg Medical Center, Newberg
  • dan 4 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05677490

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

  • Research Site, Portland
  • Research Site, Portland
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07431281

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

  • Providence Cancer Institute Franz Clinic, Portland
  • Providence Oncology and Hematology Care Clinic - Westside, Portland
  • Providence St. Vincent Medical Center- Investigational Drug Services, Portland
  • dan 1 lainnya
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT04389632

A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer

  • VA Portland Health Care System, Portland, OR, Portland
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Nov 2025 · NCT05563766

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.